Technology
Health
Pharmaceutical

Acasti Pharma

$0.9053
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0052 (0.58%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Acasti Pharma and other stocks, options, ETFs, and crypto commission-free!

About

Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. Read More The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada.

Employees
Headquarters
Laval, Québec
Founded
2002
Market Cap
70.32M
Price-Earnings Ratio
Dividend Yield
Average Volume
566.26K
High Today
$0.93
Low Today
$0.88
Open Price
$0.90
Volume
223.35K
52 Week High
$1.80
52 Week Low
$0.4333

Collections

Technology
Health
Pharmaceutical
2013 IPO
Canada
North America
Female CEOs

News

Yahoo FinanceMay 10

Acasti Settles Claims with Former Chief Executive Officer

LAVAL, Québec, May 10, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), today announced that it has settled regarding claims made against the Company by its former chief executive officer (the “Former CEO”) in respect of the termination of his employment. Pursuant to the settlement agreement, Acasti has agreed to issue 900,000 common shares from treasury (subject to applicable securities regulations) to the Former CEO. In addition, Acasti has agreed to ...

107
Yahoo FinanceApr 27

Acasti Pharma Inc. (CVE:ACST) Insiders Increased Their Holdings

We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. So before you buy or sell Acasti Pharma Inc. (CVE:ACST), you may well want to know whether insiders have been buying or selling. What Is Insider Buying? It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, such i...

254
Simply Wall StApr 26

Read This Before Selling Acasti Pharma Inc. (CVE:ACST) Shares

We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. So before you buy or sell Acasti Pharma Inc. (CVE:ACST), you may well want to know whether insiders have been buying or selling. What Is Insider Selling? Most investors know that it is quite permissible for company leaders, such as directors of the board, to buy and sell stock on the market. Howev...

70

Earnings

-$0.47
-$0.21
$0.06
$0.32
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
Actual
$0.32 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.